SMART PICU: Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study

Sponsor
Children's Hospital of Philadelphia (Other)
Overall Status
Recruiting
CT.gov ID
NCT06085326
Collaborator
Agency for Healthcare Research and Quality (AHRQ) (U.S. Fed)
3,000
6
2
60
500
8.3

Study Details

Study Description

Brief Summary

The purpose of the study is to implement a patient-provider dyad tailored, Electronic Health Record (EHR)-informed, digitized Smart Checklist as a Quality Improvement (QI) intervention to support bedside clinician teams to reduce Adverse Airway Outcomes (AAO) across 6 diverse pediatric intensive care units (ICUs).

Condition or Disease Intervention/Treatment Phase
  • Other: Smart Checklist
N/A

Detailed Description

More than 20% of the critically ill children who require tracheal intubation suffer from adverse events. To reduce the adverse event risk, and optimize bedside team performance investigators will implement a digitized Smart Checklist that has three specific features: (1) prompts based on patient characteristics, (2) direct display of difficult airway status and airway information, and (3) high-risk warning based on predictive analytics.

This is a stepped-wedge cluster randomized trial of PICU patients who are intubated across 6 participating hospitals to determine if the Smart Checklist reduces the incidence of adverse tracheal intubation associated events.

The primary objective of this study is to determine the clinical impact of the personalized, dynamic, adaptive Smart Checklist implementation on the occurrence of Adverse Airway Outcomes (AAOs) in the pediatric ICU. The secondary objective is to characterize work systems and processes that affect clinical impact of the digitized Smart Checklist.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3000 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Smart Checklist Implementation for Pediatric Tracheal Intubations in the ICU- Multicenter Study
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Jun 30, 2028
Anticipated Study Completion Date :
Sep 30, 2028

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Pre-Intervention Phase

PICU patients who are intubated without the Smart checklist

Active Comparator: Post-Intervention Phase

PICU patients who are intubated after implementation of the Smart checklist in the pediatric intensive care unit.

Other: Smart Checklist
The digitized Smart Checklist includes three new features that currently do not exist on a paper checklist: 1) decision support prompts based on patient-provider dyad characteristics, 2) real time display of patient pertinent airway information from the EHR, and 3) high-risk warning alerts based on predictive analytics with potential explanatory factors from the model.

Outcome Measures

Primary Outcome Measures

  1. Adverse Airway Outcomes [During the intubation procedure and up to 20 minutes after procedure]

    A composite outcome for adverse events or acute oxygen desaturation <80%

Secondary Outcome Measures

  1. Duration of invasive mechanical ventilation [During the ICU stay, up to 180 days]

    Duration of invasive mechanical ventilation (time to extubation or tracheostomy)

  2. Duration of ICU stay [During the ICU stay, up to 180 days]

    Duration of ICU stay (days)

  3. ICU mortality [During the ICU stay, up to 180 days]

    ICU mortality (all cause)

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 19 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

All patients intubated in the PICU at participating sites

Exclusion Criteria:

Endotracheal tube exchanges, as this represents a distinct procedure

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Arkansas Little Rock Arkansas United States 72205
2 Emory University Atlanta Georgia United States 30322
3 University of Nebraska Medical Center Omaha Nebraska United States 68198
4 Akron Children's Hospital Akron Ohio United States 44308
5 Hasbro Children's Hospital Providence Rhode Island United States 02903
6 University of Virginia Charlottesville Virginia United States 22903

Sponsors and Collaborators

  • Children's Hospital of Philadelphia
  • Agency for Healthcare Research and Quality (AHRQ)

Investigators

  • Principal Investigator: Akira Nishisaki, MD, MSCE, Children's Hospital of Philadelphia

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Children's Hospital of Philadelphia
ClinicalTrials.gov Identifier:
NCT06085326
Other Study ID Numbers:
  • 23-021168
  • R01HS029188
First Posted:
Oct 16, 2023
Last Update Posted:
Oct 16, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Children's Hospital of Philadelphia

Study Results

No Results Posted as of Oct 16, 2023